ORKA
Oruka Therapeutics, Inc.
79.50$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 10,601.5% | 81.8% | 5.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -10,501.5% | 18.2% | 95.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 2,298.6% | 91.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2,900.0% | 3,633.7% | 130.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -13,401.5% | -3,615.6% | -35.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 184.2% | 15.1% | 0.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -13,139.6% | -3,415.0% | -26.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -13,139.6% | -3,415.0% | -26.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -12,415.8% | -3,318.1% | -21.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.